2018 Outstanding Achievement in Clinical Diabetes Research Award
Rury R. Holman, FMedSci
Rury R. Holman, FMedSci, is the recipient of the 2018 Outstanding Achievement in Clinical Diabetes Research Award. This award recognizes exceptional contributions in patient-oriented clinical outcomes research that have had a significant impact on diabetes prevention and treatment.
Dr. Holman is Professor of Diabetic Medicine at the University of Oxford, Director of the University of Oxford Diabetes Trial Unit, and an NIHR Senior Investigator. Having delivered landmark clinical outcome trials over more than four decades, Dr. Holman is an exemplary clinical scientist and global leader in the field of diabetes.
Among his major accomplishments are pioneering studies in the use of basal insulin therapy for type 2 diabetes mellitus; co-invention of the first automated fingerpricker enabling home blood glucose monitoring and the first automated insulin pen, and instigator of the HOMA Calculator; co-design and operation of the 20-year UK Prospective Diabetes Study (UKPDS), which ushered in the modern era of diabetes risk factor management; and direction of the 10-year UKPDS post-trial monitoring program that identified the glucose ‘legacy effect’, which led guidelines worldwide to recommend targeting optimal blood glucose control immediately upon diagnosis of diabetes.
With more than 300 publications and more than 55,000 citations, Dr. Holman has been recognized as one of the top 400 living biomedical researchers and one of the world’s most influential scientific minds. Please join us in celebrating Rury R. Holman, FMedSci, for remarkable contributions that have substantially influenced the clinical care of diabetes.
Award Ceremony Video